Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial (AVEC)
This study is currently recruiting participants.
Study NCT00605072 Information provided by National Institute on Aging (NIA)
First Received: January 11, 2008 Last Updated: September 9, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cognitive Impairment
Hypertension
Aging
Additional conditions recognized in this trial
Cognition Disorders
More general conditions related to this trial
Cardiovascular Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Vascular Diseases
Interventions listed in this trial
candesartan
lisinopril
hydrochlorothiazide
nifedipine, long acting
metoprolol, long-acting
Additional drug interventions recognized in this trial
Antihypertensive Agents
Metoprolol
Nifedipine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Antagonists
Adrenergic beta-Antagonists
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Arrhythmia Agents
Autonomic Agents
Calcium Channel Blockers
Cardiotonic Agents
Cardiovascular Agents
Diuretics
Enzyme Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Protective Agents
Reproductive Control Agents
Sodium Chloride Symporter Inhibitors
Sympatholytics
Therapeutic Uses
Tocolytic Agents
Vasodilator Agents
Sponsors listed in this trial
National Institute on Aging (NIA)
Hebrew SeniorLife
Back to top of Main Content
